• About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
  • About
    • Our Team
    • Careers
    • Stories
  • Technology Transfer
    • Available Technologies
    • Innovators
      • Meet Our Innovators
      • Submit Disclosure
      • NAI Chapter
    • Startups
      • Meet Our Startups
    • Lab to Life
      • About Lab to Life
      • Lab to Life Process
      • Lab to Life Startups
      • Lab to Life Team
      • Lab to Life Contact
    • AI POC Grant Program
    • Workshops and Events
      • CSU Demo Day
    • FAQ
  • Real Estate Services
    • The Prospect
    • Maintenance Request Form
    • Commercial Leasing
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Newsletter Signup
  • Submit Disclosure
TECHNOLOGY TRANSFER

Innovator Profile

Photo of Ed Hoover.

Ed Hoover, PhD (In Memoriam)

Professor, Department of Microbiology, Immunology, and Pathology

Primary College

  • College of Veterinary Medicine and Biomedical Sciences

Innovator Links

  • PubMed
  • Other

Innovator Bio

Since 1982, Dr. Hoover’s laboratory focused on the mechanisms of transmission, pathogenesis, and detection of especially feline retroviruses and more recently the transmission of the prion disease chronic wasting disease (CWD) of cervids (deer, elk, moose, reindeer). Prions are important as the cause of fatal neurologic diseases of animals and models and humans disease–i.e. bovine spongiform encephalopathy (mad cow disease, BSE), sheep scrapes, and Creutzfeldt-Jakob disease. Previous research in the Hoover laboratory led to development of the first successful and most widely used feline leukemia virus (FeLV) vaccine now used to immunize cats worldwide against leukemia, and the way in which feline immunodeficiency virus (FIV) infects and causes disease in cats. Current work is focused on CWD, in particular: (1) the mechanisms whereby prions cross the mucous membranes and travel to the lymphoid tissues and then the brain to cause disease, (2) the mechanisms and cells involved in prion shedding transmission among deer, which appears to be much like the transmission of viruses; (3) the barriers to cross-species transmission of CWD to non-cervid species; and (4) experimental approaches to vaccination against this transmissible prion infection.

Innovator Technologies

MRI image of patient with Creutzfeldt-Jakob disease

A Rapid Blood Test for Early Detection of Prion Diseases

Innovator Patents

US20160116487A1. US10359434B2: In vitro detection of prions in blood.

US6042835A, NZ231744A, GR3018587T3, DE68929419T2, EP0377842B1, CA2005311C, EP0699758B1, IE83583B1: Prototype FelV isolates for use in disease models and vaccines.

Patent list generated using Google Patents.
Strata logo white
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
  • Technology Transfer
  • Real Estate Services
  • Financing Program
  • Maxwell Ranch
  • Connect
  • Equal Opportunity Employer
  • Tax Information
Serving the Colorado State University System with strategic real estate services, intellectual property protection and licensing, and financing activities.
Integrity
Reliability
Respect
Innovation
Excellence
Submit Disclosure

Newsletter Sign Up

Connect